TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 107 filers reported holding TARSUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,683,442 | +27.4% | 544,932 | +29.5% | 0.00% | – |
| Q2 2023 | $7,602,338 | +66.0% | 420,716 | +15.5% | 0.00% | – |
| Q1 2023 | $4,579,188 | -54.9% | 364,295 | -47.5% | 0.00% | – |
| Q4 2022 | $10,164,072 | +102.6% | 693,320 | +136.5% | 0.00% | – |
| Q3 2022 | $5,018,000 | +45.3% | 293,111 | +23.9% | 0.00% | – |
| Q2 2022 | $3,453,000 | +54.5% | 236,516 | +78.0% | 0.00% | – |
| Q1 2022 | $2,235,000 | -23.4% | 132,883 | +2.4% | 0.00% | – |
| Q4 2021 | $2,919,000 | +6.8% | 129,742 | +2.3% | 0.00% | – |
| Q3 2021 | $2,733,000 | -20.9% | 126,802 | +6.4% | 0.00% | – |
| Q2 2021 | $3,453,000 | +6.7% | 119,141 | +18.7% | 0.00% | – |
| Q1 2021 | $3,235,000 | -19.2% | 100,384 | +3.6% | 0.00% | – |
| Q4 2020 | $4,004,000 | – | 96,884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,417,157 | $41,069,000 | 3.79% |
| Vivo Capital, LLC | 2,987,331 | $86,573,000 | 3.75% |
| Cormorant Asset Management, LP | 1,514,269 | $43,884,000 | 1.49% |
| Ghost Tree Capital, LLC | 170,000 | $4,927,000 | 1.35% |
| RTW INVESTMENTS, LP | 2,013,601 | $58,354,000 | 0.88% |
| COWEN AND COMPANY, LLC | 514,289 | $14,904,000 | 0.78% |
| Perceptive Advisors | 2,592,832 | $75,140,000 | 0.49% |
| Altium Capital Management LP | 70,573 | $2,045,000 | 0.47% |
| TimesSquare Capital Management, LLC | 686,705 | $19,901,000 | 0.16% |
| Jefferies Group LLC | 442,993 | $12,837,937 | 0.08% |